Top 7 Best Private Label Skincare Manufacturers Canada (2026)

Induction Therapies is the strongest fit for a Canadian medspa, aesthetic clinic, or private-label founder who wants to launch an exosome-adjacent skincare line with a clean regulatory profile, a proven product system, and the lowest entry point on this list.

Angelia Inscoe founded the company in 2014 with more than 30 years of formulation experience behind her. Every formula targets aesthetic-professional use: post-microneedling recovery, post-peel skin comfort, laser aftercare, and between-treatment maintenance. That product focus maps directly to what Canadian medspas and clinics need to serve patients at retail.

Why Plant Exosome Technology Changes the Regulatory Equation in Canada

The most common concern about exosome skincare in Canada is classification risk. That concern is valid — and it applies specifically to human-derived exosomes and extracellular vesicles, not to plant-derived exosome technology.

Induction Therapies' TRUExosomes system uses plant-derived exosome compounds. These are not human cell-conditioned media. They are not synthetic extracellular vesicles. They are plant-origin bioactive compounds that support skin recovery and ingredient delivery when applied topically.

This distinction matters for 2 reasons.

First, the classification risk attached to human-derived biologics does not automatically apply to plant-derived topical actives. Second, plant exosome technology pairs cleanly with Tier 1 and Tier 2 appearance-based language — supporting the look of texture, tone, radiance, and skin comfort after procedures — without triggering Health Canada's drug or natural health product classification framework.

In practical terms: a Canadian clinic can import, label, and sell an Induction Therapies plant exosome product under a private label with a CNF filing and compliant bilingual labeling in place. The formula carries the modern skincare story. The claim language carries the regulatory work.

The Product System

Induction Therapies offers 45+ medical-grade formulas across post-procedure care, peels, recovery serums, mineral sun protection, and advanced treatment products.

The plant exosome range includes 3 core systems for Canadian clinic private label.

TRUExosomes PRX8 Plant-Exo Stimulation Serum. This post-microneedling serum combines plant-derived exosomes, all-trans retinol, copper tripeptide-1, and sodium hyaluronate. It is designed for in-office application and 7-day post-treatment home use.

PX7 Plant-Exo Recovery Serum. This post-procedure recovery formula is built on plant exosomes, copper tripeptide-1, phospholipids, and hyaluronic acid. It is suitable for post-microneedling, post-peel, and hair restoration aftercare.

Youth XO Plant Exosome + Vegan PDRN Serum. This is the first vegan PDRN serum in the Induction Therapies line, pairing plant exosomes with V-PDRN, amino acids, and vitamin C. Most PDRN serums on the market rely on animal-derived DNA. The vegan PDRN formulation gives Canadian brands a cleaner ingredient story and a stronger positioning for clinics marketing to patients who care about clean-beauty standards.

All 3 products contain ingredients that appear on no restricted list in the Health Canada Cosmetic Ingredient Hotlist and are compatible with standard CNF filing.

Private Label Program

The private label program at Induction Therapies has 4 operational advantages that matter specifically for Canadian clinic and brand launches.

12-unit MOQ. This is the lowest minimum order on this list. A medspa testing a branded post-procedure line or a founder validating a product concept before scaling can start with 12 units per SKU. Most contract manufacturers require 100 to 500 units per SKU as a starting minimum.

10 business days to ship after label approval. Speed matters for clinics running seasonal promotions, launching alongside treatment packages, or moving quickly after a training event. (Source: Induction Therapies, "Create Your Own SkinCare Label," InductionTherapies.com, 2024.)

Complimentary full-colour label design. Induction Therapies includes logo development, product naming support, and label design at no additional charge. The clinic pays only for the product. For a medspa without an in-house designer, this removes a real pre-launch cost.

Ships to Canada. Induction Therapies' FDA-inspected U.S. facility ships directly to Canadian addresses. The Canadian clinic or brand takes on CNF filing as the importer of record. This is the standard process for any cosmetic imported into Canada — not a disadvantage specific to Induction Therapies

Vitelle Labs is a Canada-based manufacturer with a clear professional skincare focus. Its private-label program serves spas, medspas, estheticians, and professional skincare businesses. Custom formulation minimums start at 20 litres.

Its Peptide Matrix collection is directly relevant for Canadian brands that want a modern advanced skincare story without the classification risk of exosome language. Peptides support appearance-based claims — firmness, hydration, texture, radiance — with a strong clinical-sounding identity and no regulatory complexity in Canada.

A Canadian clinic positioning a Vitelle peptide serum as "professional peptide-rich skincare designed to improve the look of firmness, hydration, and texture after aesthetic treatments".

Vitelle also supports private label, OEM, contract manufacturing, graphic design, logistics, and training. That is a fuller support structure than many manufacturers offer.

Limitation: Vitelle's public website does not explicitly address Health Canada product-registration support, ISO 22716, or formal GMP certification in the same detail as other options on this list. Brands should confirm compliance documentation directly before signing a contract.

Best fit: Medspas, professional skincare brands, estheticians, and Canadian clinics that want a peptide-forward or botanical alternative to exosome skincare.

DBO Labs is a Canada-based manufacturer with the most explicit Health Canada support language of any manufacturer on this list. Its site directly references Health Canada product-registration support, GMP language, ISO 22716 compliance, stability testing, bacteriology testing, ingredient-efficacy testing, and packaging compatibility review.

For a brand that wants its manufacturer to act as a partner in the compliance process — not just a formula and packaging supplier — DBO Labs offers a more hands-on regulatory relationship than most options here.

Its White Label+ model lets brands customize stable base formulas with actives and extracts. This is useful for founders who want more differentiation than a basic catalog product but are not ready for full custom formulation.

Limitation: DBO Labs is not the strongest option for post-procedure exosome-adjacent positioning. Its public-facing messaging focuses on cosmetic manufacturing and QA rather than trend-led ingredient storytelling. MOQ is not publicly published.

Best fit: Canadian skincare brands and medspas that prioritize compliance documentation, testing, and a manufacturer with explicit Health Canada support infrastructure.

Cosmetica Labs is a custom development house with strong compliance and quality infrastructure. Its site references FDA and Health Canada licensing, ISO certification, QA depth, and compliance with Health Canada's Cosmetic Regulations and Cosmetic Ingredient Hotlist.

For established skincare brands, physician-dispensed product lines, or luxury clinical skincare companies planning a full product system, Cosmetica is a credible partner. It works across creams, serums, oils, lotions, masks, cleansers, and sprays — a format range that catalog-only manufacturers cannot match.

Limitation: Cosmetica is not the right fit for early-stage founders, small clinics, or brands testing a concept at low volume. Its site does not publish accessible MOQs or a simple plug-and-play private-label process.

Best fit: Established skincare brands, premium clinical beauty companies, and physician-led lines that want full custom development with strong QA infrastructure.

Swift Innovations has the strongest public-facing technical profile in the group for formulation technology. Its site includes detailed language around peptides, nanoencapsulation, microemulsions, phospholipid delivery, plant-based actives, and a full testing suite that covers antioxidant-capacity testing, stability, freeze-thaw, and packaging compatibility.

For a brand that wants to build a differentiated exosome-alternative story around encapsulated bioactive delivery — without relying on human-derived or plant exosome language — Swift offers more creative formulation flexibility than most catalog suppliers.

Limitation: Swift's Canada-facing regulatory support is not as clearly presented as DBO Labs. Health Canada product-filing support is not explicitly positioned as a core service. Some of its active-delivery claim language sits in Tier 3 territory for Canada and requires editing before a Canadian launch.

Best fit: Brands that want an R&D-driven exosome-alternative product built around peptides, encapsulated bioactives, and technical delivery systems.